Maball-RA 500 Solution for Infusion
Marketer
Hetero Healthcare Limited
Salt Composition
Rituximab (500mg)
Overview Maball-RA 500 Solution for Infusion
Rituximab 500mg intravenous solution is indicated for treating various conditions, including non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis with polyangiitis, and microscopic polyangiitis. Administration is strictly via intravenous injection under medical supervision, with dosage and frequency determined solely by your physician based on your specific condition and may vary over time. Adhere precisely to the prescribed regimen; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic benefits might not be apparent for several weeks or months; discontinue only under your doctor's guidance. Common side effects include headache, fatigue, swelling, infections, and alopecia. This medication can lower blood cell counts, potentially increasing infection risk. Regular blood tests, including hepatitis B screening, are essential. Prior to treatment, inform your physician of any heart or liver conditions, planned surgeries or vaccinations, and all other medications, including anti-infectives, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception for both partners is crucial throughout the treatment period to prevent conception.
Uses of Maball-RA 500 Solution for Infusion
Chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and non-Hodgkin lymphoma.
Major Benefits of Maball-RA 500 Solution for Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Maball-RA 500 Solution for Infusion:
- Headache
- Weakness
- Infection
- Chills
- Decreased white blood cell count (neutrophils)
- Fever
- Infusion site reaction
- Lymphopenia
- Abdominal pain
- Back pain
How to use Maball-RA 500 Solution for Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Maball-RA 500 Solution for Infusion works:
Infuximab-RA 500, an intravenous monoclonal antibody, neutralizes aberrant B-cell activity in rheumatoid arthritis and selected malignancies.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while receiving Maball-RA 500 Solution for Infusion. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Using Maball-RA 500 Solution for Infusion during pregnancy might pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The intravenous formulation of Maball-RA 500 is likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Maball-RA 500 Solution for Infusion on driving ability is undetermined. Refrain from operating a vehicle if you encounter any symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Maball-RA 500 infusion solution appears safe for individuals with kidney impairment. Preliminary evidence indicates dose modification might be unnecessary for this patient population. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Maball-RA 500 Solution for Infusion's use in individuals with hepatic impairment. Physician consultation is advised. Maball-RA 500 Solution for Infusion is contraindicated in patients with active liver disease or a history of viral hepatitis due to the potential for infection recurrence.
What if you forget to take Maball-RA 500 Solution for Infusion :
Should you forget a scheduled Maball-RA 500 Infusion Solution dose, seek your physician's advice.
Facts to Know About Maball-RA 500 Solution for Infusion
| Label | Value |
|---|---|
| Chemical Classification | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Anti-CD20 Antibody |
3,018 People bought this recently